A new study reveals alarming links between frequent gabapentin prescriptions for chronic low back pain and increased risks of dementia and mild cognitive impairment, especially in younger adults. Learn why monitoring is essential.
A pharmacy error nearly led to tragedy for a 9-year-old boy when he was mistakenly given a potent opioid instead of his ADHD medication. His family shares their alarming experience and urges caution.
Elon Musk has publicly denied recent allegations from the New York Times about his alleged extensive use of ketamine, clarifying that he only tried it once for mental health reasons.
The White House is set to fix errors in Secretary Kennedy's 'Make America Healthy Again' report, which faced scrutiny for citing studies that don’t exist. Despite controversies, the report aims to transform public health policy.
In a surprising move, Novo Nordisk CEO Lars Fruergaard Jorgensen steps down as the company faces significant market challenges and competition from Eli Lilly's Zepbound. With share prices plummeting, the board seeks new leadership to navigate the turbulent landscape.
Pharma faces a daunting challenge as Trump takes bold steps to cut drug prices. With RFK Jr. praising the move, is bipartisanship on the horizon or will the industry fight back?
In a bold move, President Trump is set to sign an executive order mandating the U.S. health department to negotiate lower drug prices with pharmaceutical companies. This could drastically change healthcare costs for millions of Americans.
In a groundbreaking move, President Trump has issued an executive order aimed at ending the price discrimination faced by American consumers in the pharmaceutical market. This order seeks to ensure that Americans pay the same low prices for medications as those in other developed nations, addressing the long-standing issue of subsidizing global pharmaceutical profits.
In a landmark move, President Trump signs an Executive Order aimed at reducing prescription drug prices for Americans, aligning them with those in other wealthy nations. This initiative seeks to curb unfair pricing practices and ensure a fair deal for U.S. patients.
President Trump signs an executive order reviving the 'most favored nation' policy to slash drug costs by linking U.S. prices to lower prices abroad. Will this finally bring relief to American patients?
